RETRACTED: Squalene epoxidase-induced cholesteryl ester accumulation promotes nasopharyngeal carcinoma development by activating PI3K/AKT signaling (Retracted article. See vol. 113, pg. 1548, 2022)

被引:20
|
作者
Li Liming [1 ]
Zhang Qingfeng [1 ]
Wang Xin [1 ]
Li Yan [1 ]
Xie Huifen [1 ]
Chen Xiangdong [1 ]
机构
[1] Shenzhen Univ, Gen Hosp, Dept Otolaryngol Head & Neck Surg, Shenzhen, Peoples R China
关键词
AKT; cholesterol; cholesteryl ester; nasopharyngeal carcinoma; PI3K; SQLE; SERUM-CHOLESTEROL; HIGH-GRADE; CANCER;
D O I
10.1111/cas.14426
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Nasopharyngeal carcinoma (NPC) is a common malignant tumor and a major cause of mortality and morbidity in southern China. However, the mechanism is still elusive. Here, we focused on studying the role of squalene epoxidase (SQLE), a key enzyme of cholesterol biosynthesis, in the progression of NPC. Clinical study revealed that SQLE expression was significantly upregulated in NPC tissues compared to normal tissues from mRNA level and patients with high expression of SQLE showed a poor prognosis. In vitro experiments showed that SQLE overexpression led to a significant proliferation of cells whereas SQLE knockdown showed an opposite result. In vivo studies also showed that SQLE promoted tumor growth in nude mice. Further study revealed that SQLE promoted NPC proliferation by cholesteryl ester accumulation instead of cholesterol. Mechanism studies indicated that cholesteryl ester promoted NPC cell proliferation by activating the PI3K/AKT pathway and inhibition of this pathway in SQLE-overexpressed or cholesteryl ester-treated cells resulted in a significant reduction of NPC cell proliferation. These results indicate that the oncogenic effect of SQLE in NPC mainly resulted from cholesteryl ester accumulation and PI3K/AKT is a promising target for NPC with SQLE overexpression.
引用
收藏
页码:2275 / 2283
页数:9
相关论文
共 50 条
  • [21] RETRACTED: Down-regulation of HOXB5 inhibits TGF--induced migration and invasion in hepatocellular carcinoma cells via inactivation of the PI3K/Akt pathway (Retracted article. See vol. 12, pg. 27996, 2022)
    Sun, Jin-Ping
    Ge, Quan-Xing
    Ren, Zheng
    Sun, Xin-Fang
    Xie, Shu-Ping
    RSC ADVANCES, 2018, 8 (72) : 41415 - 41421
  • [22] RETRACTED: Erinacine Facilitates the Opening of the Mitochondrial Permeability Transition Pore Through the Inhibition of the PI3K/Akt/GSK-3β Signaling Pathway in Human Hepatocellular Carcinoma (Retracted article. See vol. 55, pg. 674, 2021)
    Zhou, Li-Jie
    Mo, Yan-Bo
    Bu, Xuan
    Wang, Jian-Jun
    Bai, Jing
    Zhang, Jun-Wei
    Cheng, Ai-Bin
    Ma, Ji-Hong
    Wang, Yi-Wei
    Xie, Yu-Xi
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 50 (03) : 851 - 867
  • [23] RETRACTED: METTL3 promotes the progression of nasopharyngeal carcinoma through mediating M6A modification of EZH2 (Retracted article. See vol. 26, pg. 4947, 2022)
    Meng, Q. -Z.
    Cong, C. -H.
    Li, X. -J.
    Zhu, F.
    Zhao, X.
    Chen, F. -W.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (08) : 4328 - 4336
  • [24] RETRACTED: miR-331-3p Inhibits Proliferation and Promotes Apoptosis of Nasopharyngeal Carcinoma Cells by Targeting elf4B-PI3K-AKT Pathway (Retracted article. See vol. 21, 2022)
    Zhang Xuefang
    Zheng Ruinian
    Jiang Liji
    Zhang Chun
    Zheng Qiaolan
    Jia Jun
    Chen Yuming
    Huang Junrong
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2020, 19
  • [25] RETRACTED: MiR-182 affects renal cancer cell proliferation, apoptosis, and invasion by regulating PI3K/AKT/mTOR signaling pathway (Retracted article. See vol. 24, pg. 7202, 2020)
    Fu, J. -H.
    Yang, S.
    Nan, C. -J.
    Zhou, C. -C.
    Lu, D. -Q.
    Li, S.
    Mu, H. -Q.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (02) : 351 - 357
  • [26] RETRACTED: Impairment of Central Leptin-Mediated PI3K Signaling Manifested as Hepatic Steatosis Independent of Hyperphagia and Obesity (Retracted article. See vol. 21, pg. 648, 2015)
    Warne, James P.
    Alemi, Farzad
    Reed, Alison S.
    Varonin, Jillian M.
    Chan, Helen
    Piper, Merisa L.
    Mullin, Mark E.
    Myers, Martin G., Jr.
    Corvera, Carlos U.
    Xu, Allison W.
    CELL METABOLISM, 2011, 14 (06) : 791 - 803
  • [27] RETRACTED: Inhibition of human liver cancer cell growth by evodiamine involves apoptosis and deactivation of PI3K/AKT pathway (Retracted article. See vol. 65, 2022)
    Jia, Jia
    Kang, Xigang
    Liu, Yanfang
    Zhang, Jianwei
    APPLIED BIOLOGICAL CHEMISTRY, 2020, 63 (01)
  • [28] RETRACTED: The PI3K/Akt and NF-κB signaling pathways are involved in the protective effects of Lithocarpus polystachyus (sweet tea) on APAP-induced oxidative stress injury in mice (Retracted article. See vol. 12, pg. 28658, 2022)
    Yang, Jia-yu
    Zhong, Yu-te
    Hao, Wei-nan
    Liu, Xiang-xiang
    Shen, Qiong
    Li, Yan-fei
    Ren, Shen
    Wang, Zi
    Li, Wei
    Zhao, Li-Chun
    RSC ADVANCES, 2020, 10 (31) : 18044 - 18053
  • [29] RETRACTED: AEG-1/miR-221 Axis Cooperatively Regulates the Progression of Hepatocellular Carcinoma by Targeting PTEN/PI3K/AKT Signaling Pathway (Retracted article. See vol. 23, 2022)
    Kannan, Maheshkumar
    Jayamohan, Sridharan
    Moorthy, Rajesh Kannan
    Chabattula, Siva Chander
    Ganeshan, Mathan
    Arockiam, Antony Joseph Velanganni
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (22)
  • [30] RETRACTED: Long non-coding RNA HULC promotes bladder cancer cells proliferation but inhibits apoptosis via regulation of ZIC2 and PI3K/AKT signaling pathway (Retracted article. See vol. 35, pg. 345, 2022)
    Wang, Jintao
    Ma, Weimin
    Liu, Yidong
    CANCER BIOMARKERS, 2017, 20 (04) : 425 - 434